GemVCare® (Gem stands for Genetic Evaluation & Management®) is the first Hong Kong based genetic testing company specialized in diabetes. The technology utilizes genetic tests to identify subjects who may develop diabetes and suffer from its complications. These may come in the shape of heart disease, kidney failure, stroke, early onset of cancer, which can develop due to stress and as a result of a genetic tendency.
| Company Name | GemVCare Limited |
|---|---|
| Brand Name | GemVCare |
| Industries | Healthcare BioTech |
| Year of Establishment | 2014 |
| Founder(s) | Juliana Chan |
| No. of Employees | / |
| Regional Coverage | Hong Kong |
| Clients | / |
| Stage | / |
| Investor(s) | HK Government HKSTP |
| Fundraising History | 834800 HKD (Unknown) |
| Raising Fund | / |
| Fundraising target | / |
| Pre-money valuation | / |
| Post-money Valuation | / |
| Media Exposure | PCM hk01 on.cc Headline Daily MedicalResearch.com Markets Insider |
| Company Email | [email protected] |
[dcb id=5586]